Chemotherapy-driven dysbiosis in the intestinal microbiome

Publication

Alimentary Pharmacology and Therapeutics

Author(s)

E. Montassier, T. Gastinne, P. Vangay, G. A. Al-Ghalith, S. Bruley des Varannes, S. Massart, P. Moreau, G. Potel, M. F. de La Cochetiere, E. Batard & D. Knights

Abstract

To identify functional mechanisms by which the intestinal microbiome may play a key role in the pathophysiology of GI mucositis, we applied high- throughput DNA-sequencing analysis to identify microbes and microbial functions that are modulated following chemotherapy.

Date

July 6, 2015

View study

Share this post